People's United Financial’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
PCM
LCM
FCM
ACM
CS
People's United Financial's BMY.RT Position: Q1 2020 in Review
People's United Financial sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020, closing a stake of 82,206 shares — an estimated $246K sold.
People's United Financial first reported a position in BMY.RT in Q4 2019 and held it in 1 quarter. The position peaked at $246K in Q4 2019. 581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.
- People's United Financial reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- People's United Financial sold 82,206 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2020, an estimated $246K.
- People's United Financial first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 1 quarter.
- People's United Financial's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $246K in Q4 2019.
- 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.
Based on People's United Financial's 13F filing for Q1 2020, filed 12 May 2020.